This study looked at cumulative lifetime estrogen exposure, as estimated with a mathematical index (Index of Cumulative Estrogen Exposure (ICEE)) that included variables (length of time on estrogen therapy, age at menarche and menopause, postmenopausal body mass index, time since menopause, nulliparity and duration of breastfeeding) known to influence estrogen levels across the life span, and performance on prospective and retrospective memory measures in a group of 50 postmenopausal women (mean age = 69.3 years) who, if they were current or former users of estrogen therapy, had started therapy within 5 years of menopause. The ICEE was found to be a significant predictor of performance on the Prospective Memory task (F(1) = 4.21, p = .046, g 2 p ¼ :084). No significant relationship was noted between the ICEE and performance on measures of retrospective memory. The results suggest that the level of cumulative lifetime exposure to estrogen a woman has influences her prospective memory performance later in life and that the influence of reproductive and biological markers of endogenous estrogen exposure are relevant factors to consider when studying the effect of estrogen therapy on cognitive functioning in postmenopausal women. In addition, the finding that performance on a measure of prospective memory, but not performance on measures of retrospective memory, was associated with the ICEE adds further support to the theory that the frontal cortex may be especially sensitive to estrogen.
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Introduction
While considerable evidence from basic science research supports a role for estrogen in cognitive function, the research findings from the clinical literature on estrogen therapy (ET) have been less conclusive. It has been suggested that some of the inconsistent findings could be attributed to differences in the age at which women in the studies began taking ET and that there is a ''critical window'' of time around the menopause when ET may produce a protective effect on cognitive function in postmenopausal women (Brinton, 2004; Maki, 2006; Sherwin, 2006; Sturdee & MacLennan, 2006) . The concept of a ''critical window'' is supported by the findings of a number of studies in rodents (Daniel, Hulst, & Berbling, 2006; Silva, Mello, Freymuller, Haidar, & Baracat, 2003) as well as observational (Henderson, Guthrie, Dudley, Burger, & Dennerstein, 2003; Kang, Weuve, & Grodstein, 2004; Matthews, Cauley, Yaffe, & Zmuda, 1999) and randomized controlled studies (Bagger, Tanko, Alexandersen, Qin, & Christiansen, 2005; Dunkin et al., 2005; Maki, 2005) with postmenopausal women.
The failure of previous studies that have looked at the effect of ET on cognition to include variables known to influence endogenous estrogen across the lifespan could also account for some of the inconsistencies in the findings. Age at menarche (Paganini-Hill & Henderson, 1994) , age at menopause (McLay, Maki, & Lyketos, 2003) , pregnancy (Chubak et al., 2004; Dorgan et al., 1995; Sobow & Kloszewska, 2004 ), breastfeeding (Bernstein, 2002 and postmenopausal body mass index (BMI; Grodstein, Clarkson, & Manson, 2003) all affect a woman's lifetime exposure to endogenous estrogen and there is evidence to suggest that the clinical response to ET may depend on its interaction with these variables (Dunkin et al., 2005; Rasgon et al., 2005) . Smith et al. (1999) developed an Index of Estrogen Exposure (IEE) that included variables that are well recognized to effect estrogen levels (time on ET, age at menarche and menopause, parity, postmenopausal weight and time since menopause) and examined the relationship between scores on the IEE and four factors that consisted of statistically related neuropsychological measures. After controlling for age and education, scores on the IEE were significantly related to a factor that reflected global cognitive functioning. Examining the results of a series of post hoc analyses, Smith et al. (1999) reported that no individual marker of estrogen exposure, including duration of ET, showed as consistent a pattern of relationships with
